Log in

Relevant bibliographies by topics / Prevention of thrombosis / Journal articles

To see the other types of publications on this topic, follow the link: Prevention of thrombosis.

Journal articles on the topic 'Prevention of thrombosis'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Prevention of thrombosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Rudnicka, Alicja R., Deborah Ashby, Patrick Brennan, and Tom Meade. "Thrombosis Prevention Trial." Archives of Internal Medicine 163, no. 12 (2003): 1454. http://dx.doi.org/10.1001/archinte.163.12.1454.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Strijkers, Rob HW, Mark AF de Wolf, and Cees HA Wittens. "Risk factors of postthrombotic syndrome before and after deep venous thrombosis treatment." Phlebology: The Journal of Venous Disease 32, no. 6 (2016): 384–89. http://dx.doi.org/10.1177/0268355516652010.

Full text

Abstract:

Postthrombotic syndrome is the most common complication after deep venous thrombosis. Postthrombotic syndrome is a debilitating disease and associated with decreased quality of life and high healthcare costs. Postthrombotic syndrome is a chronic disease, and causative treatment options are limited. Prevention of postthrombotic syndrome is therefore very important. Not all patients develop postthrombotic syndrome. Risk factors have been identified to try to predict the risk of developing postthrombotic syndrome. Age, gender, and recurrent deep venous thrombosis are factors that cannot be change

APA, Harvard, Vancouver, ISO, and other styles

3

Silleran-Chassany, J., and D. Safran. "Prophylaxis of Perioperative Venous Thrombosis: Role of Venous Compression." Phlebology: The Journal of Venous Disease 15, no. 3-4 (2000): 138–42. http://dx.doi.org/10.1177/026835550001500311.

Full text

Abstract:

Aim: To review the role of compression treatments in the prevention of perioperative deep venous thrombosis. Method: A review of current literature in the field of prevention of deep venous thrombosis following general and orthopaedic surgery has been conducted. Synthesis: There is a considerable risk of deep venous thrombosis following surgical treatment in hospital. This is particularly high following joint replacement in the lower limb. This may lead to fatal pulmonary embolism or chronic venous insufficiency of the lower limb with leg ulceration and disability. Perioperative deep venous th

APA, Harvard, Vancouver, ISO, and other styles

4

Cancer, Susana, Salvador Luján, and Enrique Puras. "Intraoperative Venous Balloon Angioplasty during Surgical Thoracic Outlet Decompression in Paget-Schrötter Syndrome." Vascular 12, no. 2 (2004): 136–39. http://dx.doi.org/10.1258/rsmvasc.12.2.136.

Full text

Abstract:

The management of primary subclavian-axillary vein thrombosis is controversial. Indications and time of operative or endovascular intervention after successful thrombolysis remain unresolved. To improve the long-term functional outcomes in patients with primary subclavian-axillary vein thrombosis, early reestablishment of venous patency and prevention of recurrent thrombosis are required. We present a case in which, after catheter-directed thrombolysis, positional venography showed costoclavicular compression of the subclavian vein. At the time of surgical thoracic outlet decompression, transl

APA, Harvard, Vancouver, ISO, and other styles

5

Damjanović, Miodrag, Milan Pavlović, Svetlana Apostolović, et al. "Prevention of stent thrombosis." Srce i krvni sudovi 33, no. 2 (2014): 123–27. http://dx.doi.org/10.5937/siks1402123d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Atchabahian, Arthur, and Alain C. Masquelet. "Experimental prevention of free flap thrombosis. II: Normovolemic hemodilution for thrombosis prevention." Microsurgery 17, no. 12 (1996): 714–16. http://dx.doi.org/10.1002/(sici)1098-2752(1996)17:12<714::aid-micr10>3.0.co;2-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bezlepkin, Yu A., I. N. Sonkin, A. V. Gusinskiy, et al. "COMPARISON OF LONG-TERM RESULTS OF FEMORAL VEIN LIGATION AND TRANSCATHETER THROMBOLYSIS IN THROMBOSIS OF THE FEMORAL SEGMENT." Grekov's Bulletin of Surgery 178, no. 5 (2019): 62–68. http://dx.doi.org/10.24884/0042-4625-2019-178-5-62-68.

Full text

Abstract:

INTRODUCTION. The problem of preventing massive pulmonary thromboembolism and post-thrombotic syndrome in deep vein thrombosis has been studied for a long period. The introduction of new treatments for deep vein thrombosis requires a detailed comparison of their effectiveness.The OBJECTIVE of this work was a comparative analysis of ligation of the superficial femoral vein and regional thrombolytic therapy.MATERIAL AND METHODS. A retrospective multicenter study involving 30 patients with femoproplite thrombosis, who had received catheter-directed thrombolysis or ligation of the superficial femo

APA, Harvard, Vancouver, ISO, and other styles

8

Lim, Wendy. "Prevention of thrombosis in antiphospholipid syndrome." Hematology 2016, no. 1 (2016): 707–13. http://dx.doi.org/10.1182/asheducation-2016.1.707.

Full text

Abstract:

Abstract Antiphospholipid syndrome (APS) is an acquired autoimmune condition characterized by thrombotic events, pregnancy morbidity, and laboratory evidence of antiphospholipid antibodies (aPL). Management of these patients includes the prevention of a first thrombotic episode in at-risk patients (primary prevention) and preventing recurrent thrombotic complications in patients with a history of thrombosis (secondary prevention). Assessment of thrombotic risk in these patients, balanced against estimated bleeding risks associated with antithrombotic therapy could assist clinicians in determin

APA, Harvard, Vancouver, ISO, and other styles

9

Zhang, Ning, Yuan Xu, Qiao-Dan Lu, et al. "Nurses’ knowledge, attitude, and practice in peripherally inserted central catheter-related thrombosis prophylactic practices: A multicentric cross-sectional study." Medicine 104, no. 17 (2025): e42005. https://doi.org/10.1097/md.0000000000042005.

Full text

Abstract:

Peripherally inserted central catheter (PICC)-related thrombosis is preventable, and nurses play a play a crucial role in its prevention. The implementation of nurses’ preventive practice is key to reducing the occurrence of PICC-related thrombosis. The level of nurses’ knowledge, attitude, and practice can influence the prevention of PICC-related thrombosis, which is important for reducing patient suffering. The aim of this study was to assess nurses’ knowledge, attitude, and practice level regarding PICC-related thrombosis prevention based on evidence-based guidelines. Data were collected us

APA, Harvard, Vancouver, ISO, and other styles

10

Duval, Cédric. "Fibrinogen levels and thrombosis prevention." Blood 139, no. 9 (2022): 1269–71. http://dx.doi.org/10.1182/blood.2021015051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Matthews, Hugh. "Prevention of hospital-acquired thrombosis." British Journal of General Practice 66, no. 652 (2016): 559.1–559. http://dx.doi.org/10.3399/bjgp16x687709.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Tai, Ming-Wai, and Burgunda V. Sweet. "Nattokinase for prevention of thrombosis." American Journal of Health-System Pharmacy 63, no. 12 (2006): 1121–23. http://dx.doi.org/10.2146/ajhp050509.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Verstraete, M. "Prevention of Thrombosis in Arteries." Journal of Cardiovascular Pharmacology 7 (1985): S191—S205. http://dx.doi.org/10.1097/00005344-198500073-00023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Gough, N. R. "Thrombosis Prevention Without Bleeding Extension." Science Signaling 6, no. 301 (2013): ec276-ec276. http://dx.doi.org/10.1126/scisignal.2004896.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Vaidya, Jayant S. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1204. http://dx.doi.org/10.1016/s0140-6736(98)26016-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Fahey, Tom, and Tim J. Peters. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1204–5. http://dx.doi.org/10.1016/s0140-6736(05)79150-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

lacoviello, Licia, and Maria Benedetta Donati. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1205. http://dx.doi.org/10.1016/s0140-6736(05)79151-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Jolobe, OMP. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1205. http://dx.doi.org/10.1016/s0140-6736(05)79152-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Cleland, John GF, and Ian Ford. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1205–6. http://dx.doi.org/10.1016/s0140-6736(05)79153-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Peverill, Roger E., Richard W. Harper, and Joseph J. Smolich. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1206. http://dx.doi.org/10.1016/s0140-6736(05)79154-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

FitzGerald, Garret A., and William N. Charman. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1206. http://dx.doi.org/10.1016/s0140-6736(05)79155-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Meade, TW, and PJ Brennan. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1206–7. http://dx.doi.org/10.1016/s0140-6736(05)79156-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Crunkhorn, Sarah. "Safe path to thrombosis prevention." Nature Reviews Drug Discovery 16, no. 3 (2017): 164–65. http://dx.doi.org/10.1038/nrd.2017.27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

P, Rajendra Kumar Jain, and Nishad Chitnis. "Stent thrombosis: Prevention and management." Journal of Medical and Scientific Research 2, no. 1 (2014): 5–12. http://dx.doi.org/10.17727/jmsr.2014/2-001.

Full text

Abstract:

Stent thrombosis (ST) is a persistent and important clinical problem. Stent thrombosis has been defined and classified by the Academic Research Consortium (ARC). We have reviewed the data available on the incidence of ST in various registries and trials. The incidence of ST is higher with DES compared to BMS. ST incidence is highest with first generation DES but reduces significantly with second and third generation DES. We have reviewed the factors which predict a higher incidence of ST. These can be divided into patient, lesion and procedure characteristics. The upcoming new technologies and

APA, Harvard, Vancouver, ISO, and other styles

25

Lee, Hannah, Sharelle Sturgeon, Shaun Jackson, and Justin Hamilton. "The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions." Thrombosis and Haemostasis 107, no. 02 (2012): 328–37. http://dx.doi.org/10.1160/th11-06-0418.

Full text

Abstract:

SummaryDeveloping novel anti-platelet therapies is an important clinical strategy for the prevention of arterial thromboses which cause heart attacks and most strokes. Thrombin activates platelets via protease-activated receptors (PARs), and PAR antagonists are currently under investigation as antithrombotics. Yet despite these clinical advances, the importance of PARs to platelet activation during thromboses formed under pathological conditions has not been investigated. To this end, we examined the role of PAR-dependent platelet activation in thrombus formation in the presence of elevated bl

APA, Harvard, Vancouver, ISO, and other styles

26

Melnikov, A. P., E. I. Moskovkina, and K. S. Gasanova. "Prevention of thrombosis in gynecological oncology." Clinical Medicine (Russian Journal) 102, no. 11-12 (2025): 824–30. https://doi.org/10.30629/0023-2149-2024-102-11-12-824-830.

Full text

Abstract:

This review of foreign literature addresses the pressing issue of preventing venous thromboembolic complications in the practice of modern oncogynecologists. It emphasizes the connection between the severity of the oncological process and the frequency of thromboembolic complications, the presence of which predetermines an unfavorable outcome. The review discusses methods for the prophylactic use of anticoagulants, their role in comprehensive therapy, and their interaction with other treatment methods. This work also discusses laboratory techniques for determining markers of oncological diseas

APA, Harvard, Vancouver, ISO, and other styles

27

Silva Marques, João, and Cristina Gonçalves. "Post-catheterisation arterial thrombosis in children – pathophysiology, prevention, and treatment." Cardiology in the Young 24, no. 5 (2014): 767–73. http://dx.doi.org/10.1017/s1047951114000171.

Full text

Abstract:

AbstractLower limb ischaemia is the most frequent complication of cardiac catheterisation in children. It is often overlooked, but it can cause significant disability and may limit arterial access sites to repeat diagnostic or interventional catheterisations. A narrative review of the literature on arterial access site thrombosis in children was carried out with a special focus on current evidence that supports preventive and treatment strategies. Anticoagulation, thrombolysis, and thrombectomy have been used successfully to treat arterial access site thrombosis. However, it is not completely

APA, Harvard, Vancouver, ISO, and other styles

28

Borzdova, Anastasiya, Diana Bekova, Niqar Alieva, Vladimir Ochirov, and Rashid Soliev. "Surgical Prevention of Thrombosis in Modern Condition." Journal of Complementary Medicine Research 14, no. 1 (2023): 117. http://dx.doi.org/10.5455/jcmr.2023.14.01.22.

Full text

Abstract:

The article discusses the features of surgical prevention of thrombosis in modern conditions. The author notes that due to the high risk of death, thrombosis that occurs during surgical interventions of various types have a significant impact on the quality of medical care in the surgical environment. Accordingly, it is very important to determine the risk of postoperative venous thromboembolism and evaluate the features of its prevention. A particular risk is the development of venous thromboembolism (VTE), which combines deep vein thrombosis (DVT) and pulmonary embolism (PE). Experts call it

APA, Harvard, Vancouver, ISO, and other styles

29

Popovich, Yaroslav M., Vyacheslav V. Korsak, Patricia O. Boldizhar, and Orest P. Laver. "Surgical Prevention of Thromboembolic Complications in Transfascial Thrombosis." Ukrainian Journal of Cardiovascular Surgery 31, no. 1 (2023): 66–73. http://dx.doi.org/10.30702/ujcvs/23.31(01)/pk002-6673.

Full text

Abstract:

The aim. To evaluate the effectiveness of surgical methods of prevention of venous thromboembolic complications in transfascial thrombosis of the lower extremities. Materials and methods. The paper analyzes the results of examination and surgical or conservative treatment of 417 patients with transfascial thrombosis treated at the Vascular Surgery Department of the Zakarpattia Regional Clinical Hospital named after A. Novak from 1995 to March 2020 and at the Surgical Department of the Central City Clinical Hospital of Uzhhorod from September 2020 to September 2022. The main (I) group con

APA, Harvard, Vancouver, ISO, and other styles

30

Yohannes, Senay, Tarkie Abebe, Kidist Endalkachew, and Destaw Endeshaw. "Nurses’ Knowledge, Perceived Practice, and their Associated Factors regarding Deep Venous Thrombosis (DVT) Prevention in Amhara Region Comprehensive Specialized Hospitals, Northwest Ethiopia, 2021: A Cross-Sectional Study." Critical Care Research and Practice 2022 (March 16, 2022): 1–9. http://dx.doi.org/10.1155/2022/7386597.

Full text

Abstract:

Introduction. Deep venous thrombosis is a preventable and treatable cause of death among hospitalized patients. Nurses’ knowledge and proper assessment can play a major role in improving deep venous thrombosis prevention care. Objective. To assess the knowledge, practice, and associated factors towards deep venous thrombosis prevention among nurses working at Amhara region hospitals. Methods. Institutional-based cross-sectional study was conducted among nurses working at Amhara region comprehensive specialized hospitals, Northwest, Ethiopia, from April 1 to 30, 2021. A simple random sampling t

APA, Harvard, Vancouver, ISO, and other styles

31

Jacobson, B. F. "Thrombosis - prevention is better than cure." South African Medical Journal 103, no. 4 (2013): 231. http://dx.doi.org/10.7196/samj.6808.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Gallus, A. S. "Prevention of deep leg vein thrombosis." Australian Prescriber 21, no. 2 (1998): 37–39. http://dx.doi.org/10.18773/austprescr.1998.030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Brose, Kelsey. "Cancer-Associated Thrombosis: Prevention and Treatment." Current Oncology 15, S1 (2008): 58–67. http://dx.doi.org/10.3747/co.2008.177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Davies, Mark G. "Deep Venous Thrombosis: Prevention and Treatment." Methodist DeBakey Cardiovascular Journal 5, no. 4 (2009): 25. http://dx.doi.org/10.14797/mdcvj.179.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Nicolaides, AndrewN. "Prevention of recurrent deep-vein thrombosis." Vascular Investigation and Therapy 2, no. 1 (2019): 19. http://dx.doi.org/10.4103/vit.vit_8_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Colwell, Clifford W., Mark I. Froimson, Michael A. Mont, et al. "Thrombosis Prevention After Total Hip Arthroplasty." Journal of Bone and Joint Surgery-American Volume 92, no. 3 (2010): 527–35. http://dx.doi.org/10.2106/jbjs.i.00047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Swierstra, Bart, Jeanne Stibbe, and Hubert Schouten. "Prevention of thrombosis after hip arthroplasty." Acta Orthopaedica 59, no. 2 (1988): 139–43. http://dx.doi.org/10.3109/17453678809169694.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Lowe, Gordon D. O. "Measurement of thrombosis and its prevention." British Journal of Clinical Pharmacology 54, no. 1 (2002): 96–100. http://dx.doi.org/10.1046/j.1365-2125.2002.01626.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Vinchi, Francesca. "Thrombosis Prevention: Let's Drug the Microbiome!" HemaSphere 3, no. 1 (2019): e165. http://dx.doi.org/10.1097/hs9.0000000000000165.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Eriksson, Mats, Kjeld Christensen, Tomas L. Lindahl, and Anders Larsson. "Pharmaceutical thrombosis prevention in cardiovascular disease." Expert Opinion on Investigational Drugs 11, no. 4 (2002): 553–63. http://dx.doi.org/10.1517/13543784.11.4.553.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Kakkar, V. V. "Prevention and management of venous thrombosis." British Medical Bulletin 50, no. 4 (1994): 871–903. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072931.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Swierstra, Bart A., Jeanne Stibbe, and Hubert J. A. Schouten. "Prevention of thrombosis after hip arthroplasty." Acta Orthopaedica Scandinavica 59, no. 2 (1988): 139–43. http://dx.doi.org/10.1080/17453678809169694.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Davies, Mark G. "Deep Venous Thrombosis: Prevention And Treatment." Methodist DeBakey Cardiovascular Journal 5, no. 4 (2009): 25–31. http://dx.doi.org/10.14797/mdcj-5-4-25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Lekstrom, Julie A., and William R. Bell. "Aspirin in the Prevention of Thrombosis." Medicine 70, no. 3 (1991): 161–78. http://dx.doi.org/10.1097/00005792-199105000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

PLUMLEY, P. "PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSIS." Lancet 328, no. 8509 (1986): 750. http://dx.doi.org/10.1016/s0140-6736(86)90268-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Bounameaux, H., and B. Krahenbuhl. "PREVENTION OF POSTOPERATIVE DEEP VEIN THROMBOSIS." Lancet 328, no. 8504 (1986): 456. http://dx.doi.org/10.1016/s0140-6736(86)92157-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Uldall, Robert. "Prevention of Thrombosis in Arteriovenous Fistulas." Blood Purification 3, no. 1-3 (1985): 89–93. http://dx.doi.org/10.1159/000169401.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Chard, Robin. "Perioperative prevention of deep vein thrombosis." AORN Journal 90, no. 1 (2009): 119–20. http://dx.doi.org/10.1016/j.aorn.2009.06.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Browse, N. L. "Prevention of postoperative deep vein thrombosis." British Journal of Surgery 75, no. 9 (1988): 835–36. http://dx.doi.org/10.1002/bjs.1800750903.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Cate-Hoek, A. J. Ten, M. H. Prins, C. H. A. Wittens, and H. Ten Cate. "Postintervention duration of anticoagulation in venous surgery." Phlebology: The Journal of Venous Disease 28, no. 1_suppl (2013): 105–11. http://dx.doi.org/10.1177/0268355513476415.

Full text

Abstract:

For a substantial proportion of patients with deep venous thrombosis (DVT), current treatment strategies are suboptimal and new treatment options are needed. Especially for the group of patients who are at the highest risk for post-thrombotic syndrome, new treatment modalities such as catheter-directed thrombolysis and additional stenting are being investigated. With current clinical studies addressing new technical options, the medical management of patients following these interventions deserves attention. The duration of anticoagulant treatment following surgical or radiological interventio

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!